Collegium Pharmaceutical (COLL) Retained Earnings (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Retained Earnings of -$86.6 million for Q1 2026, up 46.38% year-over-year from -$59.2 million in Q1 2025, and down 27257.68% quarter-over-quarter from $319000.0 in Q4 2025.
Collegium Pharmaceutical (COLL) Retained Earnings (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Retained Earnings history runs 13 years deep, the most recent figure standing at -$86.6 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 46.38% year-over-year to -$86.6 million; the TTM figure through Mar 2026 stood at -$86.6 million (up 46.38% YoY), while the FY2025 annual figure was $319000.0, down 99.95% from the prior year.
- Retained Earnings for Q1 2026 stood at -$86.6 million, down from $319000.0 in the prior quarter.
- The five-year high for Retained Earnings was $590.3 million in Q4 2024, with the low at -$285.8 million in Q2 2023.
- The 5-year median for Retained Earnings is -$124000.0 (2024), against an average of $66.5 million.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings jumped 4215978.57% in 2024, then sank 130208.06% in 2025.
- Collegium Pharmaceutical's Retained Earnings stood at $538.1 million in 2022, then tumbled by 100.0% to $14000.0 in 2023, then surged by 4215978.57% to $590.3 million in 2024, then plunged by 99.95% to $319000.0 in 2025, then slumped by 27257.68% to -$86.6 million in 2026.
- Business Quant data shows COLL's Retained Earnings at -$86.6 million in Q1 2026, $319000.0 in Q4 2025, and -$118.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Collegium Pharmaceutical | 897.54 Mn | 748.22 Mn | 110.29 Mn | 636.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 636.06 Mn |
| Mar 31, 2026 | -86.63 Mn |
| Dec 31, 2025 | 319,000.00 |
| Sep 30, 2025 | -118.09 Mn |
| Jun 30, 2025 | 337,000.00 |
| Mar 31, 2025 | -161.58 Mn |
| Dec 31, 2024 | 590.25 Mn |
| Sep 30, 2024 | 582.76 Mn |
| Jun 30, 2024 | -185.87 Mn |
| Mar 31, 2024 | -124,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | -265.13 Mn |
| Jun 30, 2023 | -285.76 Mn |
| Mar 31, 2023 | 540.39 Mn |
| Dec 31, 2022 | 538.07 Mn |
| Sep 30, 2022 | 525.59 Mn |
| Jun 30, 2022 | -274.60 Mn |
| Mar 31, 2022 | -269.41 Mn |
| Dec 31, 2021 | 502.10 Mn |
| Sep 30, 2021 | -231.31 Mn |